ECDC is closely monitoring increasing SARS-CoV-2 activity in the EU/EEA, and the emergence of the recently identified Omicron-descendant variant NB.1.8.1 has been associated with a rise in infections in some countries in Asia, including China, Hong Kong and Singapore.